Quantitation of Tumor Volumes and Response to Therapy with Ultrasound B-Scans

Tolbert, Donald D.; Zagzebski, James A.; Banjavie, Richard A.; Wiley, Albert L.

doi:10.1148/113.3.705

Cited by 16 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Plasma phenobarbitone levels were measured at the end of 3 weeks of drug administration. Liver volumes were determined by an ultrasonic scanning technique similar to those of Rasmussen (1972) and Tolbert, Zagzebski, Banjavic & Wiley (1974). Serial transverse scans were recorded at 1 cm intervals from the inferior limit of the liver to the upper limit at which liver outline could be clearly visualised.…”

Section: Methodsmentioning

confidence: 99%

The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Roberts¹,

Jackson²,

Halliwell³

et al. 1976

Brit J Clinical Pharma

View full text Add to dashboard Cite

General Hospital, Bristol I Liver volume and the clearances of antipyrine and indocyanine green have been measured before and after administration of phenobarbitone (180 mg/day) for 3 weeks to ten healthy subjects. 2 The measurement of liver volume by an ultrasound scanning technique yielded reproducible results which were consistent with predictions of liver size by allometric methods. 3 Before phenobarbitone, antipyrine clearance correlated with liver volume, but there was no correlation between indocyanine green clearance and liver volume. 4 Phenobarbitone administration increased the clearance of antipyrine significantly by 90 ± 14% but there was no significant change in indocyanine green clearance or liver volume. 5 After phenobarbitone the correlation between antipyrine clearance and liver volume persisted. There was no correlation between indocyanine green clearance and liver volume. 6 These results suggest that in non-medicated subjects some of the difference in antipyrine clearance is due to difference in functional hepatic parenchymal mass and that phenobarbitone increases the drug metabolising capacity per unit of hepatic mass but not total liver size.

show abstract

Section: Methodsmentioning

confidence: 99%

The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Roberts¹,

Jackson²,

Halliwell³

et al. 1976

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

“…The role of 'B' mode scanning as a fully integral part of the radiotherapy planning procedure rather than solely for post planning verification has been described by a number of workers (Eule et al, 1973;Tolbert et al, 1974;Banjavic et al, 1975;Brascho, 1974;Slater et ul, 1974;Badcock, 1977). Anatomical information has been extracted from ultrasound scans in a number of indirect ways.…”

Section: Introductionmentioning

confidence: 99%

The Role of Digital Ultrasound Scanners in Radiotherapy Planning

Waggett

Doorn

1982

Australas Radiol

View full text Add to dashboard Cite

Ultrasound scanning has been used for some years in cancer therapy not only for the detection and staging of tumours, but also to aid radiotherapy planning. The modern ultrasound scanner, provided it is fully digital, is ideally suited to accurately obtaining certain cross sectional anatomical information. By running radiotherapy planning software on the ultrasound microcomputer, interfacing problems between scanner and planning computer have been avoided. This approach offers high precision with a modest capital outlay that should prove attractive to the smaller radiotherapy centres.

show abstract